Sidera Bio ApS
Private limited companyCVR 44381699København ØActive
Sidera Bio ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2023. The company made a loss in both 2024 and 2025, most recently DKK 6.9m. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 6.6m to DKK 6.9m (2024 → 2025).
- Equity turned positive again: DKK 85.9m (2024 → 2025).
Employees
- 1 more employees than a year earlier: 6 (07/2026) against 5 (07/2025).
Management and owners, last 24 months
- New in management: Keld Flintholm Jørgensen (ceo, 03/06/2025), Stefan Emanuel Luzi (board member, 18/11/2025) and Nandita Shangari (board member, 18/11/2025) (+3).
- Stepped down: Thomas Gundelund Rasmussen (ceo, 03/06/2025) and Søren Møller (board member, 30/06/2026).
- New owners registered: Novo Holdings A/S (18/11/2025), RA Capital Healthcare Fund, L.P. (18/11/2025) and Forbion Ventures Fund VI Coöperatief U.A. (18/11/2025) (+3).
- No longer registered as owner: Origem Holding ApS (18/11/2025), BHNS Holding ApS (18/11/2025) and Forbion Ventures Fund VI Coöperatief U.A. (17/11/2025) (+1).
Registrations, last 24 months
- 12/01/2026: Share capital changed from 526,768 DKK to 567,867 DKK
- 18/11/2025: Share capital changed from 40,000 DKK to 526,768 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2024–2025 · amounts in DKK thousandEquity and net profit
| 2024 | 2025 | Change | |
|---|---|---|---|
| Revenue | not stated | not stated | – |
| Gross profit | −6,685 | −5,287 | +20.9% |
| Profit before tax | −7,365 | −7,662 | −4% |
| Net profit | −6,627 | −6,925 | −4.5% |
| Total assets | 6,277 | 88,859 | +1,315.7% |
| Equity | −6,622 | 85,864 | +1,396.7% |
| Liabilities | 12,899 | 2,995 | −76.8% |
| Cash and cash equivalents | 4,926 | 53,934 | +994.8% |
| Average number of employees | 2 | 4 | +100% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
2 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 01/07/2026 | The company | PDF not statedXBRL |
| 2024 | 19/10/2023 – 31/12/2024 | 30/06/2025 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 69,536of 69,742 Better than 0% | No. 2,058of 69,964 Better than 97% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 293of 323 Better than 9% | No. 6of 329 Better than 98% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,550of 16,614 Better than 0% | No. 234of 16,661 Better than 99% |
| All companies of type ApS66,508 companies in the comparison | No. 66,198of 66,379 Better than 0% | No. 1,318of 66,505 Better than 98% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Sidera Bio ApS−DKK 5.3m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Sidera Bio ApS−DKK 6.9m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Sidera Bio ApSDKK 85.9m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Sidera Bio ApS6
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Novo Holdings A/S15%
- RA Capital Healthcare Fund, L.P.15%
- Forbion Ventures Fund VI Coöperatief U.A.25%
- Stichting Juridisch eigendom ForCal I5%
- Coöperatieve Gilde Healthcare VG VI U.A.10%
- Samsara BioCapital, L.P.5%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Keld Flintholm Jørgensen | CEO | 03/06/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Peter Høngård Andersen | Chair of the board | 19/10/2023 |
| Stefan Emanuel Luzi | Board member | 18/11/2025 |
| Nandita Shangari | Board member | 18/11/2025 |
| Tim Lohoff | Board member | 18/11/2025 |
| Mads Peter Hemmingsen | Board member | 30/06/2026 |
- Auditor
- KPMG P/S
- Founders
- Hongaard Holding ApS, Origem Holding ApS
Former management (3)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Thomas Gundelund Rasmussen | CEO | 19/10/2023 | 03/06/2025 |
| Kasper Lage Hansen | Board member | 24/01/2024 | 29/05/2024 |
| Søren Møller | Board member | 18/11/2025 | 30/06/2026 |
Signing rule: Selskabet tegnes af bestyrelsens formand i forening med et medlem af bestyrelsen, af bestyrelsens formand i forening med et medlem af direktionen, eller af den samlede bestyrelse.
Address and production units
1 active production unitsFruebjergvej 3
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (8)
- Vektor Ejendomme A/SBuying and selling of own real estate
- Symbion A/SRenting of commercial property
- Synopsys Denmark ApSComputer consultancy and computer facilities management
- Clinical-Microbiomics A/SResearch and experimental development on natural sciences and engineering
- River Stone Biotech ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Sidera Bio ApS | Fruebjergvej 3, 2100 København Ø | 6 | 1029768796 |
Purpose
Selskabets formål er forskning, udvikling, produktion og salg af lægemidler og andre beslægtede forretningsområder efter bestyrelsens skøn.
The purpose is quoted from the register in Danish.
Changes year by year
36 registered events20265 changesaccounts 1 · management 2 · capital 1 · ownership 1
- AccountsAnnual report for 2025 published
- ManagementMads Peter Hemmingsen appointed board member
- ManagementSøren Møller stepped down as board member
- CapitalShare capital changed from 526,768 DKK to 567,867 DKK
- OwnershipSamsara BioCapital, L.P. registered as owner (5%)
202518 changescapital 1 · management 6 · ownership 9 · accounts 1 · industry 1
- CapitalShare capital changed from 40,000 DKK to 526,768 DKK
- ManagementStefan Emanuel Luzi appointed board member
- ManagementSøren Møller appointed board member
- ManagementTim Lohoff appointed board member
- ManagementNandita Shangari appointed board member
- OwnershipNovo Holdings A/S registered as owner (15%)
- OwnershipRA Capital Healthcare Fund, L.P. registered as owner (15%)
- OwnershipForbion Ventures Fund VI Coöperatief U.A. registered as owner (25%)
- OwnershipStichting Juridisch eigendom ForCal I registered as owner (5%)
- OwnershipCoöperatieve Gilde Healthcare VG VI U.A. registered as owner (10%)
- OwnershipBHNS Holding ApS is no longer registered as owner
- OwnershipMelina Claussnitzer is no longer registered as owner
- OwnershipOrigem Holding ApS is no longer registered as owner
- OwnershipForbion Ventures Fund VI Coöperatief U.A. is no longer registered as owner
- AccountsAnnual report for 2024 published
- ManagementKeld Flintholm Jørgensen appointed ceo
- ManagementThomas Gundelund Rasmussen stepped down as ceo
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20248 changesaddress 1 · management 2 · name 1 · ownership 4
- AddressMoved to Fruebjergvej 3, 2100 København Ø
- ManagementKasper Lage Hansen stepped down as board member
- NameName changed from GhostBio ApS to Sidera Bio ApS
- ManagementKasper Lage Hansen appointed board member
- OwnershipBHNS Holding ApS registered as owner (20%)
- OwnershipForbion Ventures Fund VI Coöperatief U.A. registered as owner (33.33%)
- OwnershipMelina Claussnitzer registered as owner (20%)
- OwnershipHongaard Holding ApS is no longer registered as owner
20235 changesfounded 1 · management 2 · ownership 2
- FoundedRegistered as GhostBio ApS
- ManagementThomas Gundelund Rasmussen appointed ceo
- ManagementPeter Høngård Andersen appointed chair of the board
- OwnershipOrigem Holding ApS registered as owner (5%)
- OwnershipHongaard Holding ApS registered as owner (50%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- H. Lundbeck A/Svia Peter Høngård Andersen
- Glycom A/Svia Peter Høngård Andersen
- 21st.BIO A/Svia Søren Møller
- Orbis Medicines ApSvia Søren Møller
- Freya Biosciences ApSvia Thomas Gundelund Rasmussen
- Biosyntia ApSvia Søren Møller
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.